HE4 human epididymis

Molecular Biomarkers for the Early Detection of Ovarian Cancer. (Int J Mol Sci, 2022) [PMID:36233339]
Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis. (Technol Cancer Res Treat, 2020) [PMID:33148127]
Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders. (Clin Chim Acta, 2015) [PMID:25127713]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Molecular Biomarkers for the Early Detection of Ovarian Cancer. (2022) pubmed
Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis. (2020) pubmed
Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders. (2015) pubmed
The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis. (2021) pubmed
The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis. (2022) pubmed
Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis. (2012) pubmed
Comparative Meta-Analysis of Carbohydrate Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), and Diagnostic Indices (Risk of Malignancy Index (RMI) and Risk of Ovarian Malignancy Algorithm (ROMA)) for Pre-operative Detection of Ovarian Carcinoma. (2025) pubmed
Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation. (2022) pubmed
Prognostic Role of Human Epididymis Protein4 (HE4) in Endometrial Lesions: Study in a Tertiary Care Centre. (2023) pubmed
Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis. (2022) pubmed